Suppr超能文献

开发一种用于定量分析利什曼原虫属细胞内形式的自动化图像分析方案

Development of an automated image analysis protocol for quantification of intracellular forms of Leishmania spp.

机构信息

i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal.

IBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal.

出版信息

PLoS One. 2018 Aug 2;13(8):e0201747. doi: 10.1371/journal.pone.0201747. eCollection 2018.

Abstract

Leishmania parasites cause a set of neglected tropical diseases with considerable public health impact, the leishmaniases, which are often fatal if left untreated. Since current treatments for the leishmaniases exhibit high toxicity, low efficacy and prohibitive prices, many laboratories throughout the world are engaged in research for the discovery of novel chemotherapeutics. This entails the necessity of screening large numbers of compounds against the clinically relevant form of the parasite, the obligatory intracellular amastigote, a procedure that in many laboratories is still carried out by manual inspection. To overcome this well-known bottleneck in Leishmania drug development, several studies have recently attempted to automate this process. Here we implemented an image-based high content triage assay for Leishmania which has the added advantages of using primary macrophages instead of macrophage cell lines and of enabling identification of active compounds against parasite species developing both in small individual phagolysosomes (such as L. infantum) and in large communal vacuoles (such as L. amazonensis). The automated image analysis protocol is made available for IN Cell Analyzer systems, and, importantly, also for the open-source CellProfiler software, in this way extending its implementation to any laboratory involved in drug development as well as in other aspects of Leishmania research requiring analysis of in vitro infected macrophages.

摘要

利什曼原虫寄生虫引起一组被忽视的热带病,具有相当大的公共卫生影响,即利什曼病,如果不治疗,往往是致命的。由于目前治疗利什曼病的方法毒性高、疗效低且价格昂贵,因此世界各地的许多实验室都在从事新的化学疗法药物的研究。这需要对大量化合物进行筛选,以对抗临床上相关的寄生虫形式,即必需的内体无鞭毛体,许多实验室仍在通过手动检查进行这一过程。为了克服利什曼病药物开发中的这一众所周知的瓶颈,最近有几项研究试图使这一过程自动化。在这里,我们实施了一种基于图像的高内涵初筛检测方法,用于利什曼原虫,它具有使用原代巨噬细胞而不是巨噬细胞系的额外优势,并且能够鉴定针对在小单个吞噬体(如婴儿利什曼原虫)和大共有的空泡(如亚马逊利什曼原虫)中发育的寄生虫物种的活性化合物。自动化图像分析方案可用于 IN Cell Analyzer 系统,并且重要的是,还可用于开源 CellProfiler 软件,从而将其实施扩展到参与药物开发以及需要分析体外感染巨噬细胞的其他利什曼研究方面的任何实验室。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5f16/6072083/285290f651a2/pone.0201747.g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验